Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Vomiting × Pantoprazole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 3 Neoplasm Metastasis 2 Vomiting 1 Stomach Neoplasms 1 Spinal Cord Compression 1 Prostatic Neoplasms 1 Pancreatitis 1 Pancreatic Neoplasms 1 Ototoxicity 1 Osteosarcoma 1 Helicobacter Infections 1 Gastritis, Atrophic 1 Duodenal Neoplasms 1 Delayed Bleeding 1 Breast Neoplasms 1 Advanced Solid Tumours 1

Interventions

Dexamethasone 35 Aprepitant 30 Palonosetron 24 Ondansetron 21 Granisetron 14 fosaprepitant 13 Calcium Dobesilate 12 Olanzapine 11 Therapeutics 7 ramosetron 6 dexamethasone acetate 5 Tropisetron 5 Doxorubicin 5 Cyclophosphamide 5 Metoclopramide 4 netupitant, palosentron drug combination 3 netupitant 3 dolasetron 3 dexamethasone 21-phosphate 3 Vincristine 3 Surveys and Questionnaires 3 Prochlorperazine 3 Lorazepam 3 Dronabinol 3 Diphenhydramine 3 Acupressure 3 ginger extract 2 Thalidomide 2 Sugars 2 Radiotherapy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03948477 2022-05-25

PantoCIN

University of Auckland, New Zealand

Phase 2 Completed

Breast Neoplasms, Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡